<?xml version="1.0" encoding="UTF-8"?>
<p id="p0205">SARS-CoV-2 was first detected in human bronchoalveolar lavage (BAL) specimens by unbiased Illumina and nanopore sequencing technologies, and a real-time RT-PCR assay using pan-betacoronavirus degenerate primers targeting a highly conserved RdRp region (
 <xref rid="bb0715" ref-type="bibr">Zhu et al., 2020</xref>). The SARS-CoV-2 isolation was performed in different cell lines, including human airway epithelial cells, Vero E6, and Huh-7. Cytopathic effects were observed in human airway epithelial cells 4Â days after inoculation, but not in Vero E6 and Huh-7 (
 <xref rid="bb0715" ref-type="bibr">Zhu et al., 2020</xref>). For safety, CDC recommends that clinical virology laboratories should not attempt viral isolation from clinical specimens collected from COVID-19 patients under investigation (PUIs).
</p>
